\n<\/p>\n
HONG KONG SAR – Members of Sisram Medical\u2019s management team and board of directors will host a conference call to discuss the first half financial results in more detail on Monday, August 22, 2022, at 8:30 a.m. Eastern Time. Speakers will include The Company encourages participants to The conference call will be commenced at:<\/span>\n<\/p>\n 8:30 a.m. Eastern Time A replay will also be available on Sisram Medical\u2019s Event\u2019s page at: <\/span>https:\/\/sisram-medical.com\/investors\/events-presentations\/<\/span><\/a><\/span>.<\/span>\n<\/p>\n Hashtag: <\/b>#SisramMedical<\/p>\n
\nMedia OutReach<\/a> –
\n11 August 2022 – Sisram Medical Ltd <\/b>(the <\/b>\u201cCompany<\/b>\u201d <\/b>or <\/b>\u201cSisram<\/b>\u201d, stock code:
\n 1696.HK<\/b>; together with its subsidiaries referred as the \u201cGroup<\/b>\u201d), <\/b><\/span>a<\/span> global leading provider of energy-based surgical and medical aesthetics solutions, <\/span>today announced that it expects to hold a conference call regarding its financial results for the first half of 2022, ended June 30, 2022, on Monday, August 22, 2022.<\/span>
\n <\/span><\/p>\n
\n Mr. Liu YI, Sisram\u2019s Chairman and Executive Director<\/b>, <\/span>and <\/span>Mr. Lior DAYAN, Sisram\u2019s Chief Executive Officer<\/span><\/b>,
\n Mr. Guojun BU, Sisram\u2019s CFO<\/b>,
\n Mr. Doron YANNAI, Alma\u2019s CFO<\/b>,
\n Ms. Qianli FANG, Sisram\u2019s Company Secretary, Investment & IR Director<\/b>, following the prepared remarks they will also be available for a Q&A session.
\n pre-register for the conference call using the follow link<\/b>: <\/span>https:\/\/AlmaLasers.activetrail.biz\/Sisram-IR-form<\/span><\/a><\/span>. Callers will receive dial-in details upon registration, which enables immediate access on the day of the call. Participants may pre-register at any time, including up to and after the call start time.<\/span>\n<\/p>\n
\n
5:30 a.m. Pacific Time
\n
3:30 p.m. Israel Time<\/span>\n<\/p>\n